TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25102706

Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine (Group B) 80 ml
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.125% levobupivacaine (Group L) 80 ml
Number of subjects: 90

Group type: COMPARATOR
Intervention: 0.09% NaCl (Group P) 80 ml
Number of subjects: 90
Study: 22183173

Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg with low-fat meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg with moderate-fat meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg with high-fat meal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dolutegravir 50 mg in fasted state
Number of subjects: 0
Study: 19558712

Group type: EXPERIMENTAL
Intervention: Well London project interventions focusing on healthy eating, physical activity, and mental health and wellbeing, implemented in 20 areas.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group of matched areas not receiving the Well London project interventions.
Number of subjects: 40
Study: 17029554

Group type: EXPERIMENTAL
Intervention: Chewing mastic gum for 15 minutes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chewing mastic gum for 135 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (chewing paraffin)
Number of subjects: 0
Study: 16610179

Group type: EXPERIMENTAL
Intervention: Non-closure of peritoneum
Number of subjects: 80

Group type: COMPARATOR
Intervention: Closure of peritoneum
Number of subjects: 80
Study: 11907660

Group type: EXPERIMENTAL
Intervention: COPD patients requiring mechanical ventilation
Number of subjects: 63

Group type: COMPARATOR
Intervention: Stable COPD patients on long-term oxygen therapy
Number of subjects: 63
Study: 11122795

Group type: EXPERIMENTAL
Intervention: Primary therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with autologous hematopoietic support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sentinel node biopsy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biologic markers
Number of subjects: 0
Study: 8800784

Group type: EXPERIMENTAL
Intervention: Micronized 17 beta‐oestradiol (2 mg/day) continuously with dydrogesterone (10 mg/day) for the first 14 days of each cycle
Number of subjects: 48
Study: 2192334

Group type: EXPERIMENTAL
Intervention: Periodontal treatment (scaling, root planing, and periodontal surgery)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (contralateral teeth)
Number of subjects: 10
Study: 7382628

Group type: EXPERIMENTAL
Intervention: Digoxine alone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Digoxine plus amiodarone hydrochloride
Number of subjects: 40
Study: 31048187

Group type: EXPERIMENTAL
Intervention: Hydrocellular dressings (ALLEVYN Adhesive®)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Hydrocolloid dressings (VARIHESIVE® GEL CONTROL)
Number of subjects: 169
Study: 28714725

Group type: EXPERIMENTAL
Intervention: Substance use prevention (SP) intervention
Number of subjects: 4158

Group type: COMPARATOR
Intervention: Comparison intervention (energy balance behaviors)
Number of subjects: 4158
Study: 25097091

Group type: EXPERIMENTAL
Intervention: Dynamic load perception in stroke survivors
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Coordination in stroke survivors
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Proprioception in stroke survivors
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Balance in stroke survivors
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Gait symmetry in stroke survivors
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Correlation of gait symmetry with static and dynamic load perception measures
Number of subjects: 10
Study: 25228971

Group type: EXPERIMENTAL
Intervention: Second-look endoscopy (SLE)
Number of subjects: 437

Group type: COMPARATOR
Intervention: Non-second-look endoscopy (non-SLE)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: SLE for lesions with a large tumor size (>20 mm)
Number of subjects: 437

Group type: COMPARATOR
Intervention: Non-SLE for lesions with a large tumor size (>20 mm)
Number of subjects: 437
Study: 23161301

Group type: EXPERIMENTAL
Intervention: peginterferon alfa‐2a (40KD; 180 μg/week)
Number of subjects: 113
Study: 18722086

Group type: EXPERIMENTAL
Intervention: Method of Assessing Treatment Delivery (MATD)
Number of subjects: 0
Study: 17484873

Group type: EXPERIMENTAL
Intervention: Ribavirin
Number of subjects: 31
Study: 15172894

Group type: EXPERIMENTAL
Intervention: Intranasal budesonide for 2 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 12297843

Group type: EXPERIMENTAL
Intervention: Extracorporeal albumin dialysis (ECAD)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard medical therapy (SMT)
Number of subjects: 24
Study: 9839843

Group type: EXPERIMENTAL
Intervention: PES at 100 Hz
Number of subjects: 9

Group type: COMPARATOR
Intervention: PES at 20 Hz
Number of subjects: 9
Study: 8088139

Group type: EXPERIMENTAL
Intervention: 1% SLS solution
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 2% SLS solution
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 5% SLS solution
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 7.5% SLS solution
Number of subjects: 11

Group type: COMPARATOR
Intervention: Deionized water (control)
Number of subjects: 11
Study: 2732866

Group type: EXPERIMENTAL
Intervention: Rapid refeeding (RR)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Gradual refeeding (GR)
Number of subjects: 52
Study: 1234581

Group type: EXPERIMENTAL
Intervention: Constant insulin doses
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Variable insulin doses
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Addition of biguanides (metformin)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no biguanides)
Number of subjects: 43
Study: 31691287

Group type: EXPERIMENTAL
Intervention: School environment factors (perceptions of safety and support, student attitudes to learning)
Number of subjects: 2278

Group type: EXPERIMENTAL
Intervention: School environment
Number of subjects: 2278

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 2278
Study: 28063908

Group type: EXPERIMENTAL
Intervention: Ultrasonic energy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Monopolar energy
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Barbed suture
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nonbarbed suture
Number of subjects: 20
Study: 25745751

Group type: EXPERIMENTAL
Intervention: Cabergoline (Cb2) 0.5 mg oral per day for 8 consecutive days starting on the day of hCG administration
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cabergoline (Cb2)
Number of subjects: 40
Study: 23290081

Group type: EXPERIMENTAL
Intervention: Atrasentan (10 mg)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 21592347

Group type: EXPERIMENTAL
Intervention: All Nations Breath of Life (ANBL) program
Number of subjects: 448

Group type: COMPARATOR
Intervention: Current Best Practices smoking cessation program
Number of subjects: 448
Study: 19448514

Group type: EXPERIMENTAL
Intervention: Latex-free leg bag with soft elastic straps and cloth backing
Number of subjects: 43

Group type: COMPARATOR
Intervention: Latex leg bag with latex straps and noncoated backing
Number of subjects: 43
Study: 17031013

Group type: EXPERIMENTAL
Intervention: 5 microg of vitamin D3 daily
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 10 microg of vitamin D3 daily
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 20 microg of vitamin D3 daily
Number of subjects: 49

Group type: COMPARATOR
Intervention: 0 microg of vitamin D3 daily (placebo)
Number of subjects: 49
Study: 12474195

Group type: EXPERIMENTAL
Intervention: Healthy weight control intervention
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Dissonance-based intervention
Number of subjects: 148

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 148
Study: 11281090

Group type: EXPERIMENTAL
Intervention: FERN Dissemination (FERN-D) program with e-mail discussions
Number of subjects: 34

Group type: COMPARATOR
Intervention: Preintervention and postintervention surveys
Number of subjects: 34
Study: 9314645

Group type: EXPERIMENTAL
Intervention: Unfractioned heparin
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 8338443

Group type: EXPERIMENTAL
Intervention: Polyester filters (Optima, Sepacell R500, and Pall RC100)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cellulose acetate filter (Cellselect)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Polyester filters
Number of subjects: 20
Study: 3327683

Group type: EXPERIMENTAL
Intervention: Felodipine (0.075 mg/kg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Felodipine added to beta-blockade
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 25
Study: 29895045

Group type: EXPERIMENTAL
Intervention: Intervention group (34 children) participated in two gaming sessions (1.5 hours each) and an oral presentation about smoking and alcohol risks.
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (33 children) participated in an oral presentation about smoking and alcohol risks.
Number of subjects: 67
Study: 27075030

Group type: EXPERIMENTAL
Intervention: 160 mg of intracuff alkalinized lidocaine
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 80
Study: 24955797

Group type: EXPERIMENTAL
Intervention: 50 mg/kg/day cephalexin syrup, administered in four doses for 10 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 40
Study: 22156952

Group type: EXPERIMENTAL
Intervention: Community health workers (CHWs) assisting patients with diabetes in self-management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control health centers (without CHWs)
Number of subjects: 0
Study: 19966314

Group type: EXPERIMENTAL
Intervention: Psychological interventions for procedural pain management
Number of subjects: 28
Study: 18798236

Group type: EXPERIMENTAL
Intervention: Magnetic Navigation System (MNS)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Conventional guidewire techniques
Number of subjects: 111
Study: 16397157

Group type: EXPERIMENTAL
Intervention: Intervention programs designed based on formative research methods including telephone interviews, surveys, checklists, semistructured interviews, and focus group discussions.
Number of subjects: 0
Study: 15259838

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Supportive Expressive Group Psychotherapy (SEGP)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 63
Study: 11134123

Group type: EXPERIMENTAL
Intervention: 50 mg oral DHEA daily for 12 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo after DHEA treatment
Number of subjects: 39
Study: 9072856

Group type: EXPERIMENTAL
Intervention: Polyglyconate sutures
Number of subjects: 204

Group type: COMPARATOR
Intervention: Polyglycolic acid sutures
Number of subjects: 204
Study: 8441490

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic energy (Diapulse)
Number of subjects: 50
Study: 3023457

Group type: EXPERIMENTAL
Intervention: Topical alpha interferon gel (10^5 U) with nonoxynol 9 applied three times daily for 5 days
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Topical alpha interferon gel (10^7 U) with nonoxynol 9 applied three times daily for 5 days
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 31206501

Group type: EXPERIMENTAL
Intervention: Preoperative plasma neutrophil gelatinase‐associated lipocalin levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 24-hour postoperative plasma neutrophil gelatinase‐associated lipocalin levels
Number of subjects: 0
Study: 29457585

Group type: EXPERIMENTAL
Intervention: Learning Disability Epilepsy Specialist Nurse Competency Framework
Number of subjects: 312

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 312
Study: 27881888

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of Telmisartan and Ramipril
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no treatment mentioned)
Number of subjects: 24
Study: 25302016

Group type: EXPERIMENTAL
Intervention: KM-023 75 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: KM-023 150 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: KM-023 300 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: KM-023 600 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Multiple doses of KM-023 75 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Multiple doses of KM-023 600 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 23176532

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 130

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 130
Study: 20213036

Group type: EXPERIMENTAL
Intervention: Deep dry needling
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham dry needling
Number of subjects: 12
Study: 17631698

Group type: EXPERIMENTAL
Intervention: SR-CAP (sustained-release pellet formulation of diclofenac, 100 mg, once daily)
Number of subjects: 210

Group type: COMPARATOR
Intervention: SR-TAB (standard reference formulation of diclofenac, 100 mg, once daily)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: SR-CAP
Number of subjects: 210

Group type: COMPARATOR
Intervention: SR-TAB
Number of subjects: 210
Study: 14966017

Group type: EXPERIMENTAL
Intervention: Optimal ventilation waveform (OVW) approach with six frequencies from 0.156 to 4.6 Hz
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Bronchoconstriction (methacholine challenge)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Seated position
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 6
Study: 11391056

Group type: EXPERIMENTAL
Intervention: Tridimensional personality questionnaire
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novelty seeking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personality and alcohol/substance use disorder
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three-pathway psychobiological model
Number of subjects: 0
Study: 9839583

Group type: EXPERIMENTAL
Intervention: Varicocele group (29 men)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (28 men)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (38 men)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Varicocele group (24 men)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 57
Study: 7859964

Group type: EXPERIMENTAL
Intervention: 1 g of intravenous cefotaxime
Number of subjects: 31

Group type: COMPARATOR
Intervention: No antibiotic (control)
Number of subjects: 31
Study: 2911170

Group type: EXPERIMENTAL
Intervention: Dexamethasone acetate 4 mg every six hours for six doses starting at exposure (2700 m)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo every six hours for six doses starting at exposure (2700 m)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Dexamethasone acetate 4 mg every six hours for six doses starting at exposure (2050 m)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo every six hours for six doses starting at exposure (2050 m)
Number of subjects: 73
Study: 4584707

Group type: EXPERIMENTAL
Intervention: 40 mug of Sch 1000
Number of subjects: 20

Group type: COMPARATOR
Intervention: 200 mug of salbutamol
Number of subjects: 20
Study: 30571292

Group type: EXPERIMENTAL
Intervention: Continuous walking after breakfast (WALK)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Breaks from sitting after each meal (BR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30
Study: 28473871

Group type: EXPERIMENTAL
Intervention: Lateral wedge insoles with custom arch support
Number of subjects: 26

Group type: COMPARATOR
Intervention: Lateral wedge insoles alone
Number of subjects: 26
Study: 26262568

Group type: EXPERIMENTAL
Intervention: Cable Pin System (CPS)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Tension-Band Wiring (TBW)
Number of subjects: 73
Study: 23453439

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 2314

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 2314
Study: 21287560

Group type: EXPERIMENTAL
Intervention: Minocycline (2 × 50 mg/d)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 19938199

Group type: EXPERIMENTAL
Intervention: Transnasal small‐caliber EGD
Number of subjects: 270

Group type: COMPARATOR
Intervention: Transoral conventional EGD
Number of subjects: 270
Study: 16814009

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral (CB) treatment
Number of subjects: 1873

Group type: EXPERIMENTAL
Intervention: 12-step treatment
Number of subjects: 1873
Study: 15035271

Group type: EXPERIMENTAL
Intervention: High-dose mannitol treatment (approximately 1.4 g/kg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional-dose mannitol treatment (approximately 0.7 g/kg)
Number of subjects: 44
Study: 11318075

Group type: EXPERIMENTAL
Intervention: 85% NPH insulin and 15% regular human insulin (85/15)
Number of subjects: 36

Group type: COMPARATOR
Intervention: 70% NPH/30% regular human insulin (70/30)
Number of subjects: 36

Group type: COMPARATOR
Intervention: 100% NPH insulin
Number of subjects: 36
Study: 9390580

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 58

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 58
Study: 7965607

Group type: EXPERIMENTAL
Intervention: Participants who received education about consensus bias and feedback about actual consensus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants attributing bias to another person
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants exposed to unanimous information from 20 randomly chosen others
Number of subjects: 0
Study: 3580233

Group type: EXPERIMENTAL
Intervention: morphine 10 mg plus cisapride 10 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: morphine 10 mg plus cisapride 4 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: morphine 10 mg plus placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo only
Number of subjects: 40
Study: 31351965

Group type: EXPERIMENTAL
Intervention: GZ389988A (tropomyosin receptor kinase A inhibitor)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 27900763

Group type: COMPARATOR
Intervention: parecoxib+propacetamol
Number of subjects: 253

Group type: COMPARATOR
Intervention: parecoxib
Number of subjects: 253

Group type: COMPARATOR
Intervention: propacetamol
Number of subjects: 253
Study: 26520225

Group type: EXPERIMENTAL
Intervention: Singleton detection training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Feature search training
Number of subjects: 0
Study: 21807366

Group type: EXPERIMENTAL
Intervention: Training and implementation modules provided to facility staff
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Staff training and implementation modules augmented by surveyor training
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard training
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Training staff and surveyors
Number of subjects: 45
Study: 21035132

Group type: EXPERIMENTAL
Intervention: levobupivacaine (150 mg) + lidocaine (200 mg) + tramadol (100 mg) (Group T)
Number of subjects: 40

Group type: COMPARATOR
Intervention: levobupivacaine (150 mg) + lidocaine (200 mg) (Group C)
Number of subjects: 40
Study: 19536421

Group type: EXPERIMENTAL
Intervention: NutriAlz intervention program
Number of subjects: 946

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 946
Study: 16934043

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 12628875

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate for 6 weeks followed by nasal saline solution irrigation for 6 weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: Nasal saline solution irrigation for 12 weeks (for children without chronic sinusitis)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Aggressive treatment for sinusitis
Number of subjects: 61
Study: 10671845

Group type: EXPERIMENTAL
Intervention: Buffered lidocaine 1%
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Counter-irritation technique
Number of subjects: 122

Group type: COMPARATOR
Intervention: Warmed lidocaine 1%
Number of subjects: 122
Study: 9354220

Group type: EXPERIMENTAL
Intervention: Saline instillation (1 mL/kg; maximum 10 mL) before catheter removal
Number of subjects: 404

Group type: COMPARATOR
Intervention: Control group (no saline instillation)
Number of subjects: 404
Study: 8518976

Group type: EXPERIMENTAL
Intervention: Amitriptyline (100 mg each evening)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 2439825

Group type: EXPERIMENTAL
Intervention: Propranolol (4 X 40 mg/day)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Alprenolol (4 X 100 mg/day)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Pindolol (2 X 5 mg/day)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Bopindolol (2 mg/day)
Number of subjects: 4
Study: 29433687

Group type: EXPERIMENTAL
Intervention: Ze 185
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 72
Study: 30427135

Group type: EXPERIMENTAL
Intervention: Dermal equivalent (DE) applied on trophic ulcers in addition to standard treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard treatment only
Number of subjects: 60
Study: 25518175

Group type: EXPERIMENTAL
Intervention: CT-based, patient-specific cutting blocks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Contemporary instrumentation with alignment at 3 degrees external rotation from posterior condylar line
Number of subjects: 80
Study: 21982583

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 56